KCM
Kingdon Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-67,055
| Closed | -$824K | – | 115 |
|
|
2017
Q3 | $824K | Sell |
67,055
-539,355
| -89% | -$6.63M | 0.05% | 90 |
|
|
2017
Q2 | $9.98M | Sell |
606,410
-1,083,863
| -64% | -$17.8M | 0.68% | 41 |
|
|
2017
Q1 | $24.2M | Buy |
1,690,273
+472,698
| +39% | +$6.78M | 1.33% | 20 |
|
|
2016
Q4 | $16.8M | Buy |
1,217,575
+407,909
| +50% | +$5.64M | 0.81% | 28 |
|
|
2016
Q3 | $14.6M | Buy |
809,666
+315,286
| +64% | +$5.7M | 0.67% | 32 |
|
|
2016
Q2 | $7.09M | Sell |
494,380
-30,000
| -6% | -$430K | 0.39% | 51 |
|
|
2016
Q1 | $6.27M | Sell |
524,380
-250,000
| -32% | -$2.99M | 0.34% | 53 |
|
|
2015
Q4 | $10.3M | Buy |
774,380
+249,380
| +48% | +$3.32M | 0.5% | 40 |
|
|
2015
Q3 | $5.64M | Buy |
+525,000
| New | +$5.64M | 0.27% | 56 |
|